Thus, the 15-mer peptide mix may act as CD8+ T-cell-induced vaccines or immune monitoring tools for the efficacy of COVID-19 vaccines in high-risk HLA-A24+ patients with HM. This evidence concerns the gene CD8A and COVID-19.